Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK and Dundee to find new drugs for tropical diseases with Wellcome Trust funding

This article was originally published in Scrip

Executive Summary

The development of new drugs for neglected tropical diseases is the subject of the latest agreement between GlaxoSmithKline and the University of Dundee. The partnership will focus on a series of preclinical compounds for leishmaniasis, Chagas' disease and African sleeping sickness, supported by a grant of £8.6 million from the Wellcome Trust.

You may also be interested in...



New EU Patent System On Course For End Of 2020, Says EPO

Progress is being made towards the implementation of the EU’s new patent system, but the UK’s insistence on severing all ties with the European Court could spell the end for its participation.

EMA On Track To Install New Chief In November

The recruitment process for the new executive director of the European Medicines Agency seems to be running to schedule.

Six-Month Delay For Russia’s Track And Trace System

Russia’s new drug traceability system won’t now be implemented until July, but companies that are ready and able are being encouraged to put the system through its paces in order to flush out any glitches.

Topics

Related Companies

UsernamePublicRestriction

Register

SC016509

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel